Five critically ill patients with laboratory-confirmed COVID-19 and AARDS were treated with CP transfusion, conducted at Shenzhen Third People's Hospital in China. Patients received transfusion of CP that had been obtained from five patients who had recovered from COVID-19. In this uncontrolled case study, the administration of convalescent plasma containing neutralizing antibody was followed by improvement in their clinical status.